Q1 2025 Management View Veru highlighted its transformation into a late clinical-stage biopharmaceutical company focusing on cardiometabolic and inflammatory diseases, with major developments in ...

Discover how small biotechs are innovating in the weight loss therapy market with new treatments targeting unique mechanisms ...

More than 40 percent of Qataris are clinically obese, due to sedentary lifestyles, genetic factors, and cultural preferences ...

There are no studies documenting the percentage of doctors taking the drugs. But physicians “are a good litmus test for drugs ...